205 related articles for article (PubMed ID: 37400282)
1. Impacts of routine varicella vaccination program and COVID-19 pandemic on varicella and herpes zoster incidence and health resource use among children in Japan.
Uda K; Okubo Y; Tsuge M; Tsukahara H; Miyairi I
Vaccine; 2023 Jul; 41(34):4958-4966. PubMed ID: 37400282
[TBL] [Abstract][Full Text] [Related]
2. Effect of universal varicella vaccination and behavioral changes against coronavirus disease 2019 pandemic on the incidence of herpes zoster.
Shiraki K; Toyama N; Tanaka K; Ito A; Yamamoto J;
J Dermatol Sci; 2021 Dec; 104(3):185-192. PubMed ID: 34836716
[TBL] [Abstract][Full Text] [Related]
3. Trends in varicella and herpes zoster epidemiology before and after the implementation of universal one-dose varicella vaccination over one decade in South Korea, 2003-2015.
Choi JK; Park SH; Park S; Choi SM; Kim SH; Lee DG; Yoo JH; Choi JH; Kang JH
Hum Vaccin Immunother; 2019; 15(11):2554-2560. PubMed ID: 31008679
[No Abstract] [Full Text] [Related]
4. Cost-effectiveness of varicella and herpes zoster vaccination in Sweden: An economic evaluation using a dynamic transmission model.
Wolff E; Widgren K; Scalia Tomba G; Roth A; Lep T; Andersson S
PLoS One; 2021; 16(5):e0251644. PubMed ID: 33984060
[TBL] [Abstract][Full Text] [Related]
5. Vaccination to prevent varicella: Goldman and King's response to Myers' interpretation of Varicella Active Surveillance Project data.
Goldman GS; King PG
Hum Exp Toxicol; 2014 Aug; 33(8):886-93. PubMed ID: 24275643
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of pediatric herpes zoster after varicella infection: a population-based study.
Wen SY; Liu WL
Pediatrics; 2015 Mar; 135(3):e565-71. PubMed ID: 25713285
[TBL] [Abstract][Full Text] [Related]
7. Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006.
Wood SM; Shah SS; Steenhoff AP; Rutstein RM
Pediatrics; 2008 Jan; 121(1):e150-6. PubMed ID: 18086820
[TBL] [Abstract][Full Text] [Related]
8. Descriptive epidemiology of varicella based on national surveillance data before and after the introduction of routine varicella vaccination with two doses in Japan, 2000-2017.
Morino S; Tanaka-Taya K; Satoh H; Arai S; Takahashi T; Sunagawa T; Oishi K
Vaccine; 2018 Sep; 36(40):5977-5982. PubMed ID: 30166199
[TBL] [Abstract][Full Text] [Related]
9. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
Marchetti S; Guzzetta G; Flem E; Mirinaviciute G; Scalia Tomba G; Manfredi P
Vaccine; 2018 Feb; 36(8):1116-1125. PubMed ID: 29366704
[TBL] [Abstract][Full Text] [Related]
10. Twenty Years of Medically-Attended Pediatric Varicella and Herpes Zoster in Ontario, Canada: A Population-Based Study.
Wormsbecker AE; Wang J; Rosella LC; Kwong JC; Seo CY; Crowcroft NS; Deeks SL
PLoS One; 2015; 10(7):e0129483. PubMed ID: 26177077
[TBL] [Abstract][Full Text] [Related]
11. The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013.
Hobbelen PH; Stowe J; Amirthalingam G; Miller L; van Hoek AJ
J Infect; 2016 Sep; 73(3):241-53. PubMed ID: 27283754
[TBL] [Abstract][Full Text] [Related]
12. Changes in epidemiological characteristics and sero-prevalence against the varicella zoster virus in school-age children after the introduction of a national immunization program in Japan.
Yasui Y; Mitsui T; Arima F; Uchida K; Inokuchi M; Tokumura M; Nakayama T
Hum Vaccin Immunother; 2021 Aug; 17(8):2494-2500. PubMed ID: 33650932
[TBL] [Abstract][Full Text] [Related]
13. Early impact of universal varicella vaccination on childhood varicella and herpes zoster hospitalizations in Brazil.
Scotta MC; Paternina-de la Ossa R; Lumertz MS; Jones MH; Mattiello R; Pinto LA
Vaccine; 2018 Jan; 36(2):280-284. PubMed ID: 29198917
[TBL] [Abstract][Full Text] [Related]
14. Point-Counterpoint: The Hope-Simpson Hypothesis and Its Implications Regarding an Effect of Routine Varicella Vaccination on Herpes Zoster Incidence.
Harpaz R; van Hoek AJ
J Infect Dis; 2018 Sep; 218(suppl_2):S57-S62. PubMed ID: 30247602
[TBL] [Abstract][Full Text] [Related]
15. Routine varicella vaccination program and hospitalization for herpes zoster in Japan.
Kuniyoshi Y; Tokutake H; Takahashi N; Kamura A; Yasuda S; Tashiro M
Hum Vaccin Immunother; 2021 Nov; 17(11):4171-4176. PubMed ID: 34613868
[TBL] [Abstract][Full Text] [Related]
16. Development of varicella vaccine in Japan and future prospects.
Ozaki T; Asano Y
Vaccine; 2016 Jun; 34(29):3427-33. PubMed ID: 27160039
[TBL] [Abstract][Full Text] [Related]
17. Varicella-zoster virus: pathogenesis, incidence patterns and vaccination programs.
Gabutti G; Franchi M; Maniscalco L; Stefanati A
Minerva Pediatr; 2016 Jun; 68(3):213-25. PubMed ID: 27125440
[TBL] [Abstract][Full Text] [Related]
18. Different vaccination strategies in Spain and its impact on severe varicella and zoster.
Gil-Prieto R; Walter S; Gonzalez-Escalada A; Garcia-Garcia L; Marín-García P; Gil-de-Miguel A
Vaccine; 2014 Jan; 32(2):277-83. PubMed ID: 24275483
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Varicella Vaccination on the Incidence of Varicella and Herpes Zoster in the United States: Updated Evidence From Observational Databases, 1991-2016.
Wolfson LJ; Daniels VJ; Altland A; Black W; Huang W; Ou W
Clin Infect Dis; 2020 Mar; 70(6):995-1002. PubMed ID: 31147680
[TBL] [Abstract][Full Text] [Related]
20. The impact of 2-dose routine measles, mumps, rubella, and varicella vaccination in France on the epidemiology of varicella and zoster using a dynamic model with an empirical contact matrix.
Ouwens MJ; Littlewood KJ; Sauboin C; Téhard B; Denis F; Boëlle PY; Alain S
Clin Ther; 2015 Apr; 37(4):816-829.e10. PubMed ID: 25726457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
